Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)

19.51
+0.23
+(1.19%)
At close: April 30 at 3:04:40 PM GMT+8
Loading Chart for 300753.SZ
  • Previous Close 19.28
  • Open 21.13
  • Bid 19.53 x --
  • Ask 19.54 x --
  • Day's Range 19.22 - 19.78
  • 52 Week Range 10.06 - 30.97
  • Volume 5,951,143
  • Avg. Volume 12,422,382
  • Market Cap (intraday) 2.459B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.06
  • Earnings Date --
  • Forward Dividend & Yield 0.07 (0.33%)
  • Ex-Dividend Date Jun 3, 2024
  • 1y Target Est --

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.

www.apon.com.cn

608

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300753.SZ

View More

Performance Overview: 300753.SZ

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300753.SZ
10.66%
SSE Composite Index (000001.SS)
2.17%

1-Year Return

300753.SZ
61.59%
SSE Composite Index (000001.SS)
5.61%

3-Year Return

300753.SZ
57.06%
SSE Composite Index (000001.SS)
7.61%

5-Year Return

300753.SZ
19.79%
SSE Composite Index (000001.SS)
14.65%

Compare To: 300753.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300753.SZ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    2.46B

  • Enterprise Value

    2.34B

  • Trailing P/E

    227.65

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.46

  • Price/Book (mrq)

    3.61

  • Enterprise Value/Revenue

    6.25

  • Enterprise Value/EBITDA

    1.18k

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.68%

  • Return on Assets (ttm)

    1.31%

  • Return on Equity (ttm)

    1.55%

  • Revenue (ttm)

    403.8M

  • Net Income Avi to Common (ttm)

    10.8M

  • Diluted EPS (ttm)

    -0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    202.64M

  • Total Debt/Equity (mrq)

    11.58%

  • Levered Free Cash Flow (ttm)

    -3.55M

Research Analysis: 300753.SZ

View More

Company Insights: 300753.SZ

Research Reports: 300753.SZ

View More

People Also Watch